MarketPulse
L

$LGND

3 articles found
1 positive
0 negative
2 neutral
BenzingaBenzinga··Vandana Singh

BofA Initiates Buy on Ligand Pharma, Sees $244 Upside in Royalty Model

Bank of America initiates Buy coverage on Ligand Pharmaceuticals with $244 price target, citing differentiated royalty model and strong Q4 results beating earnings expectations.
LGNDportfolio diversificationearnings beat
The Motley FoolThe Motley Fool··Jonathan Ponciano

Ashford Capital Expands Vicor Position as Power Conversion Demand Accelerates

Ashford Capital increased its Vicor position by $10.94M, betting on sustained demand for power conversion tech in AI and data center infrastructure.
VTIVICRGSATLGNDaerospace and defensedata centers
The Motley FoolThe Motley Fool··Jonathan Ponciano

Ashford Capital Trims $11M Cavco Position Amid Portfolio Rebalancing

Ashford Capital sold $11M of Cavco Industries shares, cutting stake from 3.1% to 1.87% in portfolio rebalancing. Cavco shows operational strength despite underperforming broader markets.
VTIGSATLGNDCVCOfund sellingcapital rotation